Final results of a phase I study of the Raf-1 kinase inhibitor BAY 43-9006 in patients with advanced refractory solid tumours Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Hirte, H
  • Moore, M
  • Hotte, Sebastien
  • Oza, A
  • Siu, L
  • Harris, H
  • MacLean, M
  • Petrenciuc, O
  • Fiander, W
  • Lathia, C

publication date

  • November 1, 2002